Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aceragen Inc ACGN

Aceragen, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. The Company’s pipeline includes ACG-701 to treat cystic fibrosis (CF) pulmonary exacerbations (PEx) and melioidosis, and... see more

Recent & Breaking News (NDAQ:ACGN)

United Parcel Service, Endurance International Group, Idera Pharmaceuticals, Aptevo Therapeutics, and Electro Scientific Industries — Future Expectations, Projections Moving into 2018

GlobeNewswire December 11, 2018

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

Benzinga.com  December 8, 2018

Idera Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire November 6, 2018

58 Biggest Movers From Friday

Benzinga.com  October 22, 2018

Idera Pharmaceuticals Presents Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Unresectable or Metastatic Melanoma Following Failure of PD-1 Inhibitor Treatment at the 2018 European Society for Medical Oncology (ES

GlobeNewswire October 19, 2018

Report: Developing Opportunities within Callon Petroleum, National Oilwell Varco, GameStop, Papa John's International, Baker Hughes, a GE company, and Idera Pharmaceuticals — Future Expectations, Projections Moving into 2018

GlobeNewswire October 15, 2018

Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors

GlobeNewswire September 18, 2018

Idera Pharmaceuticals Announces Corporate Organizational Changes

GlobeNewswire September 11, 2018

Idera Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference

GlobeNewswire August 30, 2018

Idera Pharmaceuticals To Present at the 2018 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 9, 2018

Idera Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire August 2, 2018

Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split

GlobeNewswire July 27, 2018

Idera Pharmaceuticals Provides Update on Corporate Strategy and Outlook

GlobeNewswire July 16, 2018

Idera Pharmaceuticals Announces Termination of Merger Agreement with BioCryst Pharmaceuticals

GlobeNewswire July 10, 2018

Great Point Partners, LLC Remains Opposed To The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.

PR Newswire June 20, 2018

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference

GlobeNewswire June 13, 2018

Idera Pharmaceuticals Reports Results from Phase 2 Trial of IMO-8400 in Dermatomyositis

GlobeNewswire June 12, 2018

Idera Pharmaceuticals Presents Clinical Data from the ILLUMINATE-204 Trial of the Combination of tilsotolimod and ipilimumab for Anti-PD-1 Refractory Metastatic Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire June 4, 2018

The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines

Benzinga.com  June 3, 2018

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

GlobeNewswire May 24, 2018